Most venture-backed AI companies treat federal funding as something that belongs to an earlier stage — a pre-seed play for university spinouts and garage-phase startups. This is a strategic error worth millions. The NSF's SBIR and STTR programs routinely award between $250,000 and over $1 million per project, and they are explicitly designed for small businesses with fewer than 500 employees developing high-potential technologies. That description fits the majority of Series B AI companies in the United States.
The math is straightforward. A $1 million SBIR Phase II award is non-dilutive capital — it costs your cap table nothing. At a stage where every equity round is priced against traction and burn rate, that is not a rounding error. It is a strategic asset that extends runway, funds R&D that venture investors want to see de-risked, and signals to future investors that your technology has passed federal peer review.
In March 2026, the NSF announced the AI-Ready America initiative in partnership with the Department of Labor, the Small Business Administration, and USDA's National Institute of Food and Agriculture. The program is establishing AI-Ready Coordination Hubs in every U.S. state and territory, and its three focus areas — expanding AI literacy, equipping small businesses with AI adoption tools, and building applied learning pathways — create direct alignment opportunities for AI companies whose products serve these missions.
The NSF's Artificial Intelligence topic under SBIR/STTR is explicitly broad, covering deep learning systems, computer vision, natural language processing, and any AI system that interacts with humans in personalized contexts. The program emphasizes technologies that are safe, robust against adversaries, privacy-preserving, and computationally efficient. If your product meets those criteria — and most responsible AI companies are building toward them — the alignment is not a stretch. It is a match.
But here is where most growth-stage companies stumble: compliance architecture. Federal grants come with reporting requirements, cost allocation standards, and restrictions on how funds can be deployed. Companies accustomed to venture capital — where a wire transfer arrives and a board seat is the primary oversight mechanism — are not structured for this. The result is either botched applications that never get funded, or worse, funded grants that trigger compliance failures downstream.
New York State compounds the opportunity. The Innovation Matching Grants Program through Empire State Development's NYSTAR provides matching funds for federal SBIR and STTR awards — up to $100,000 for Phase I and up to $200,000 for Phase II. This means a New York-based AI company that secures a $1 million federal SBIR Phase II can stack an additional $200,000 in state matching funds on top — all non-dilutive, all equity-preserving.
The companies that capture this capital are the ones that treat government funding not as an afterthought but as a parallel capital strategy — one that requires its own compliance infrastructure, its own application expertise, and its own advisory relationship. The ones that don't will continue to dilute themselves unnecessarily while their competitors compound an advantage that grows with every funding cycle.
Themis Advisory Group helps growth-stage AI companies identify, pursue, and structurally prepare for federal and state grant programs. Begin a conversation.